Immunoaffinity-free chromatographic purification of ovarian cancer biomarker CA125 (MUC16) from blood serum enables mass spectrometry characterization
Analytical Methods · 2024 · 16 (37) · 6337-6348
DOI: 10.1039/d4ay01172d ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Methods, 2024. Verfasst von Naviya Schuster-Little und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Kansas, Lawrence, KS, USA. rwhelan1@ku.edu. Hauptthemen laut MEDLINE: Ovarian Neoplasms, CA-125 Antigen, Biomarkers, Tumor, Membrane Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, Department of Obstetrics and Gynecology, University of Wisconsin-Madison.
Abstract (Originalsprache)
The enrichment of trace proteins from human fluid samples is of great importance in diverse clinical and industrial applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Kansas, Lawrence, KS, USA. rwhelan1@ku.edu.
- Ralph N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, KS, USA.
- Mass Spectrometry and Analytical Proteomics Laboratory, University of Kansas, Lawrence, KS, USA.
- Department of Food Science, University of Wisconsin-Madison, Madison, WI, USA.
- Department of Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, WI, USA.
ORCID-Profile: Naviya Schuster-Little, Anita Saraf, Manish S Patankar, Rebecca J Whelan
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- Department of Obstetrics and Gynecology, University of Wisconsin-Madison
- NIH Office of the Director
- University of Kansas
- National Cancer Institute
- National Institute of General Medical Sciences
Zitieren
APA
Schuster-Little, N., Sokolovsky, A. D., Gentry, A., Saraf, A., Etzel, M. R., Patankar, M. S., & Whelan, R. J. (2024). Immunoaffinity-free chromatographic purification of ovarian cancer biomarker CA125 (MUC16) from blood serum enables mass spectrometry characterization. Analytical Methods, 16(37), 6337-6348. https://doi.org/10.1039/d4ay01172d
Vancouver
Schuster-Little N, Sokolovsky AD, Gentry A, Saraf A, Etzel MR, Patankar MS, et al. Immunoaffinity-free chromatographic purification of ovarian cancer biomarker CA125 (MUC16) from blood serum enables mass spectrometry characterization. Analytical Methods. 2024;16(37):6337-6348. doi:10.1039/d4ay01172d
BibTeX
@article{SchusterLittle2024,
author = {Schuster-Little, Naviya and Sokolovsky, Andrew D and Gentry, Ashten and Saraf, Anita and Etzel, Mark R and Patankar, Manish S and Whelan, Rebecca J},
title = {Immunoaffinity-free chromatographic purification of ovarian cancer biomarker CA125 (MUC16) from blood serum enables mass spectrometry characterization},
journal = {Analytical Methods},
year = {2024},
volume = {16},
number = {37},
pages = {6337--6348},
doi = {10.1039/d4ay01172d}
}
EUVIMED